What is the average price target for PENUMBRA INC (PEN) stock?
23 analysts have analysed PEN and the average price target is 365.95 USD. This implies a price increase of 9.36% is expected in the next year compared to the current price of 334.62.
NYSE:PEN • US70975L1070
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PENUMBRA INC (PEN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-26 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-01-20 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2026-01-20 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2026-01-16 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2026-01-16 | BTIG | Downgrade | Buy -> Neutral |
| 2026-01-16 | Needham | Downgrade | Buy -> Hold |
| 2026-01-16 | Truist Securities | Downgrade | Buy -> Hold |
| 2026-01-16 | Baird | Downgrade | Outperform -> Neutral |
| 2026-01-16 | Citigroup | Downgrade | Buy -> Neutral |
| 2026-01-16 | Jefferies | Downgrade | Buy -> Hold |
| 2026-01-15 | William Blair | Downgrade | Outperform -> Market Perform |
| 2026-01-15 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2026-01-05 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-18 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-18 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-12-17 | Needham | Maintains | Buy -> Buy |
| 2025-12-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-11 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-11-06 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-27 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-27 | Needham | Reiterate | Buy -> Buy |
| 2025-10-15 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-08 | Needham | Upgrade | Hold -> Buy |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.059B 24.96% | 1.195B 12.86% | 1.404B 17.50% | 1.604B 14.27% | 1.822B 13.59% | 2.066B 13.39% | 2.271B 9.92% | 2.625B 15.59% | |
| EBITDA YoY % growth | 119.023M 291.27% | 109.926M -7.64% | 206.72M 88.05% | 313.18M 51.50% | 387.72M 23.80% | 435.19M 12.24% | 451.47M 3.74% | 610.04M 35.12% | |
| EBIT YoY % growth | 91.766M 1,404.36% | 86.224M -6.04% | 189.249M 119.49% | 257.91M 36.28% | 329.68M 27.83% | 396.87M 20.38% | 425.99M 7.34% | 574.69M 34.91% | |
| Operating Margin | 8.67% | 7.22% | 13.48% | 16.08% | 18.09% | 19.21% | 18.76% | 21.89% | |
| EPS YoY % growth | 2.09 1,129.41% | 2.87 37.32% | 3.84 33.80% | 5.11 33.19% | 6.52 27.51% | 8.12 24.49% | 8.89 9.56% | 11.17 25.59% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.09 31.26% | 1.21 41.15% | 1.33 37.08% | 1.49 26.07% | 1.42 30.25% | 1.52 25.57% | 1.60 20.02% | 1.76 18.22% |
| Revenue Q2Q % growth | 374.96M 15.68% | 393.18M 15.83% | 406.77M 14.68% | 416.89M 8.17% | 423.28M 12.89% | 444.56M 13.07% | 460.48M 13.20% | 470.65M 12.90% |
| EBITDA Q2Q % growth | 70.795M 56.06% | 76.275M 48.54% | 81.503M 31.78% | 89.936M 17.25% | 75.821M 7.10% | 82.355M 7.97% | 86.82M 6.52% | 89.314M -0.69% |
| EBIT Q2Q % growth | 54.418M 34.86% | 61.033M 49.49% | 66.514M 36.19% | 76.027M 28.35% | 69.872M 28.40% | 76.245M 24.92% | 80.558M 21.11% | 82.911M 9.05% |
All data in USD
23 analysts have analysed PEN and the average price target is 365.95 USD. This implies a price increase of 9.36% is expected in the next year compared to the current price of 334.62.
PENUMBRA INC (PEN) will report earnings on 2026-04-21, after the market close.
The consensus EPS estimate for the next earnings of PENUMBRA INC (PEN) is 1.09 USD and the consensus revenue estimate is 374.96M USD.
The consensus rating for PENUMBRA INC (PEN) is 69.5652 / 100 . This indicates that analysts generally have a neutral outlook on the stock.